- Revenue Cycle Management
- COVID-19
- Reimbursement
- Diabetes Awareness Month
- Risk Management
- Patient Retention
- Staffing
- Medical Economics® 100th Anniversary
- Coding and documentation
- Business of Endocrinology
- Telehealth
- Physicians Financial News
- Cybersecurity
- Cardiovascular Clinical Consult
- Locum Tenens, brought to you by LocumLife®
- Weight Management
- Business of Women's Health
- Practice Efficiency
- Finance and Wealth
- EHRs
- Remote Patient Monitoring
- Sponsored Webinars
- Medical Technology
- Billing and collections
- Acute Pain Management
- Exclusive Content
- Value-based Care
- Business of Pediatrics
- Concierge Medicine 2.0 by Castle Connolly Private Health Partners
- Practice Growth
- Concierge Medicine
- Business of Cardiology
- Implementing the Topcon Ocular Telehealth Platform
- Malpractice
- Influenza
- Sexual Health
- Chronic Conditions
- Technology
- Legal and Policy
- Money
- Opinion
- Vaccines
- Practice Management
- Patient Relations
- Careers
Recalling heart pumps; recycling antiobesity injectors; it’s in the water, or not – Morning Medical Update
The top news stories in medicine today.
© kwanchaichaiudom - stock.adobe.com
The U.S. Food and Drug Administration has issued the most serious recall on the HeartMate II and HeartMate 3 Left Ventricular Assist Systems due to buildup that can obstruct the device, making it less effective in helping the heart pump blood. That condition can lead to serious injuries or death.
Antiobesity drugs are one of the hottest topics in health care right now. As more people get prescriptions for them, what will happen to all the plastic pen injectors that patients are using? Big Pharma has hopes and plans for recycling.
Communities across the nation add fluoride to the water treated by municipal systems, but not all do. Questions about its effectiveness against tooth decay and possible other health side effects spark strong feelings for and against using it. Read more in this report by KFF Health News.
